Ophthalmology & Visual Sciences

James Folk, MD

Portrait

Mailing Address

Office: 11196J PFP
Iowa City, IA 52242
Phone: +1 319 356 4338
Email: james-folk@uiowa.edu

Education

BS, Science, Penn State University, 1975
MD, Medicine, Thomas Jefferson Medical College, Philadelphia, Pennsylvania, 1977
Residency, Ophthalmology, Eye & Ear Hospital, Pittsburgh, 1980
Fellowship, Vitreoretinal, The University of Iowa Hispitlas & Clinics, 1981

Appointments

Primary: Ophthalmology & Visual Sciences

Research Interests

genetics of age-related macular degeneration (AMD), inflammatory mediators in patients with posterior uveitis, treatment of wet AMD

Research Summary

Dr. Folk's main research involves the genetics of age-related macular degeneration and is a collaboration with scientists in the Center for Macular Degeneration. His role is to review patient records and photographs to determine that patients have AMD and their clinical outcomes. These findings are compared to genetic findings to: discover new genes in AMD; correlate genotype to phenotype; determine the responses of specific genotypes to various therapies. He is also studying patients with AMD due to mutations in the fibulin genes. Dr. Folk was the principal investigator at Iowa for the Complications of AMD Trial. He is a member of the Executive Board and on the writing committee for the two main outcome papers of this study. He is the principal investigator at Iowa of the Age-Related Eye Disease Study 2 which is a trial testing whether supplements of omega-3-polyunsaturated fatty acids and/or lutein with zeaxanthin slows the progression of the disease. He will also be the principal investigator at Iowa of the Complications of AMD Trial which will test Avastin and Lucentis as well as fixed dosing versus ?as needed? dosing of these drugs in the treatment of wet AMD. Dr. Folk is also collecting demographic information, medical history, blood for genetic studies, and serum for studies on inflammatory mediators in patients with posterior uveitis.

Publications

  • Proteomic analysis of vitreous biopsy techniques. Retina 32(10) : 2141-9, 2012. [PubMed]
  • Calpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degeneration. PLoS Genet 8(10) : e1003001, 2012. [PubMed]
  • Diagnostic and therapeutic challenges. Retina 32(9) : 1988-93, 2012. [PubMed]
  • Validation of tablet-based evaluation of color fundus images. Retina 32(8) : 1629-35, 2012. [PubMed]
  • Intravitreal bevacizumab for peripapillary choroidal neovascular membranes. Arch Ophthalmol 130(8) : 1073-5, 2012. [PubMed]
  • Genetic variants within chromosome 4q28.3 are not reproducibly associated with age-related macular degeneration (AMD). Acta Ophthalmol 89(7) : e603-4, 2011. [PubMed]
  • Automated measurement of the arteriolar-to-venular width ratio in digital color fundus photographs. IEEE Trans Med Imaging 30(11) : 1941-50, 2011. [PubMed]
  • Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia. Retina 31(9) : 1848-55, 2011. [PubMed]
  • Sutureless triplanar sclerotomy for 23-gauge vitrectomy. Arch Ophthalmol 129(5) : 585-90, 2011. [PubMed]
  • Intraoperative choroidal detachment during 23-gauge vitrectomy. Retina 31(5) : 893-901, 2011. [PubMed]